» Authors » Zhong-Yang Shen

Zhong-Yang Shen

Explore the profile of Zhong-Yang Shen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 131
Citations 843
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Yin M, Song H, Yang Y, Zheng W, Liu T, Shen Z
World J Gastroenterol . 2024 Nov; 30(44):4768-4770. PMID: 39610771
[This corrects the article on p. 4016 in vol. 23, PMID: 28652655.].
2.
Wang H, Wang Z, Zhang S, Kong D, Yang R, Cao L, et al.
World J Gastroenterol . 2023 Jun; 29(20):3084-3102. PMID: 37346150
Background: Capecitabine (CAP) is a classic antimetabolic drug and has shown potential antirejection effects after liver transplantation (LT) in clinical studies. Our previous study showed that metronomic CAP can cause...
3.
4.
Zhang N, Zheng J, Wu Y, Lv J, Zhang S, Zhang Y, et al.
Cancer Med . 2022 Aug; 12(3):2312-2324. PMID: 36016484
Background: Liver transplantation (LT), resection (LR), and ablation (LA) are three curative-intent treatment options for patients with early hepatocellular carcinoma (HCC). We aimed to develop a prognostic calculator to compare...
5.
Wang H, Fu Y, Song W, Mo C, Feng G, Zhao J, et al.
World J Gastrointest Surg . 2021 Oct; 13(9):988-999. PMID: 34621475
Background: Enteric anastomotic (EA) bleeding is a potentially life-threatening surgical complication associated with enteric anastomosis during simultaneous pancreas and kidney transplantation (SPKT). Aim: To investigate whether suture ligation (SL) for...
6.
Jiang W, Yang J, Xie Y, Guo Q, Tian D, Li J, et al.
World J Gastroenterol . 2021 Mar; 27(7):654-665. PMID: 33642835
Background: The most effective treatment for advanced cirrhosis and portal hypertension is liver transplantation (LT). However, splenomegaly and hypersplenism can persist even after LT in patients with massive splenomegaly. Aim:...
7.
Cao H, Yang L, Hou B, Sun D, Lin L, Song H, et al.
Stem Cell Res Ther . 2020 Jun; 11(1):218. PMID: 32503631
Background: Donation after circulatory death (DCD) liver grafts have a poor prognosis after transplantation. We investigated whether the outcome of DCD donor organs can be improved by heme oxygenase 1...
8.
Li J, Tian D, Jiang W, Shen Z
Eur J Gastroenterol Hepatol . 2020 May; 33(1):4-8. PMID: 32398492
After half a century of development, auxiliary liver transplantation (ALT) technology gradually matured and major indications of ALT have been gradually expanded. This review summarized the history of ALT and...
9.
Cai X, Wang G, Liang R, Wang L, Liu T, Zou J, et al.
Cell Transplant . 2020 May; 29:963689720903691. PMID: 32364405
During the process of human islet isolation a cascade of stressful events are triggered and negatively influence islet yield, viability, and function, including the production of proinflammatory cytokines and activation...
10.
Yang L, Cao H, Sun D, Hou B, Lin L, Shen Z, et al.
Cell Tissue Res . 2020 Apr; 381(2):239-254. PMID: 32347385
Donation after circulatory death (DCD) can expand the donor pool effectively. A gap remains in outcome between DCD livers and living donor livers, warranting improved DCD liver quality and urgent...